""Northern Light Mercy Hospital carries out the healing work of Christ by providing clinically excellent, compassionate health care for all, with special concern for the poor and disadvantaged.""

During the past decade, Mercy Hospital conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 27 clinical trials were completed, i.e. on average, 158.8% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 15 clinical trials were completed. i.e. 750% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mercy Hospital" #1 sponsor was "SCRI Development Innovations, LLC" with 14 trials, followed by "SWOG Cancer Research Network" with 12 trials sponsored, "National Cancer Institute (NCI)" with 8 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored and "NSABP Foundation Inc" with 3 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 22 trials as a collaborator, "Bristol-Myers Squibb" with 6 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator, "NCIC Clinical Trials Group" with 6 trials as a collaborator and "SWOG Cancer Research Network" with 4 trials as a collaborator. Other collaborators include 22 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Mercy Hospital" are "Breast Cancer" (12 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Metastatic Breast Cancer" (4 trials) and "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (3 trials). Many other conditions were trialed in "Mercy Hospital" in a lesser frequency.

Most popular intervention types in "Mercy Hospital" are "Drug" (45 trials), "Other" (25 trials), "Biological" (9 trials), "Procedure" (4 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (19 trials), "Docetaxel" (9 trials), "Cyclophosphamide" (7 trials), "Paclitaxel" (7 trials) and "Quality-of-Life Assessment" (7 trials). Other intervention names were less common.

The vast majority of trials in "Mercy Hospital" are 34 trials for "All" genders and 15 trials for "Female" genders.

Currently, there are NaN active trials in "Mercy Hospital". undefined are not yet recruiting, 5 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in Mercy Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Mercy Hospital, 1 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".

Mercy Hospital has several departments that took part in Clinical trials: "Lafayette Family Cancer Center-EMMC" - 119 trials, "CancerCare of Maine at Eastern Maine Medical Center" - 73 trials, "Northeast Cardiology Associates" - 16 trials, "Mercy Oncology / Hematology Center; Oncology" - 2 trials